Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psyched Wellness is a Canadian public life sciences and consumer wellness company developing and commercializing Amanita muscaria-derived health and wellness products. Its core asset is AME-1, a proprietary extract produced through a natural double-decarboxylation process designed to increase muscimol content while reducing ibotenic acid and other unwanted compounds. The company markets consumer products including Calm and Calmer for sleep, relaxation, and stress support, and has also advanced a dietary supplement shot product called Santa. Psyched Wellness positions itself as a science-backed, first-to-market developer of standardized Amanita muscaria products for human consumption. In addition to commercial sales, it has conducted preclinical safety work, stability testing, and regulatory submissions around AME-1.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Psyched Wellness.